Phillipsburg, NJ – INFINITT North America (INA), a leading provider of innovative healthcare IT solutions, is proud to announce the upcoming launch of its cutting-edge Breast MRI Tracking Solution. This powerful new tool, set to debut this fall, promises to transform the way breast MRI exams are tracked and managed.
Built on INA’s MQSA-compliant Mammography Portal framework, the Breast MRI Tracking Solution streamlines workflows and enhances patient care through its robust suite of features. These include a dedicated Breast MRI Worklist for effortless documentation of BI-RADS assessments and biopsy lesion details, comprehensive patient breast history tracking, and sophisticated letter management capabilities for BI-RADS (lay) letters and reminder letters.
The solution also boasts an extensive library of statistical reports, providing invaluable insights into audit data, procedure lists, patient outcomes, biopsy results, and radiologists’ performance. Furthermore, seamless integration with INFINITT’s Patient Portal ensures a holistic and patient-centric approach to care.
INA collaborated closely with New York Cancer and Blood Specialists (NYCB), an existing INFINITT client, to develop this solution. Senior Vice President of Imaging East at NYCB, Timothy Wintz said, “Breast MRI tracking is crucial for early detection and personalized care. By closely monitoring changes, we empower patients and enhance outcomes, ensuring every journey is guided by precision and compassion. Collaborating with INFINITT to develop our breast MRI tracking system has been a fantastic experience. Their expertise and support have made the process smooth and empowering, enhancing our ability to provide top-notch patient care.”
NYCB’s invaluable insights and expertise were instrumental in shaping the solution to meet the real-world needs of healthcare providers and their patients.
“We are thrilled to bring this game-changing solution to market,” said Michael Higgins, Chief Product Officer, INFINITT North America. “Our Breast MRI Tracking Solution represents a major leap forward in breast imaging management, and we are confident it will have a profound impact on patient care and outcomes. We look forward to rolling it out this fall and continuing to innovate for the betterment of healthcare.”